IMAX Form 144: planned sale of 20,586 shares, $704,566.14 value

IMAX filed a Form 144 indicating a proposed sale of 20,586 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $704,566.14 and an approximate sale date of 11/10/2025.

Rhea-AI Filing Summary

IMAX filed a Form 144 indicating a proposed sale of 20,586 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $704,566.14 and an approximate sale date of 11/10/2025.

The shares to be sold were acquired via restricted stock vesting under a registered plan: 17,586 on 03/07/2024 and 3,000 on 03/07/2023, each for services rendered. Shares outstanding were 53,798,934; this is a baseline figure, not the amount being offered.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did IMAX disclose on Form 144?

A proposed sale of 20,586 common shares with an aggregate market value of $704,566.14.

When is the approximate sale date for the IMAX shares?

The filing lists an approximate sale date of 11/10/2025.

Which broker is handling the proposed IMAX share sale?

The broker is Morgan Stanley Smith Barney LLC (Executive Financial Services).

On which exchange are the IMAX shares expected to be sold?

The filing names the NYSE.

How were the IMAX shares being sold originally acquired?

Through restricted stock vesting under a registered plan on 03/07/2024 (17,586) and 03/07/2023 (3,000), for services rendered.

How many IMAX shares are outstanding according to the filing?

The filing lists 53,798,934 shares outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/10/2025 - 04:51 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001620534
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IMAX CORPORATION
SEC File Number	001-35066
Address of Issuer	2525 Speakman Drive Mississauga ONTARIO, CANADA L5K 1B1
Phone	905-403-6500
Name of Person for Whose Account the Securities are To Be Sold	PABLO M CALAMERA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20586	704566.14	53798934	11/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/07/2024	Restricted stock vesting under a registered plan	Issuer			17586	03/07/2024	Services Rendered
Common	03/07/2023	Restricted stock vesting under a registered plan	Issuer			3000	03/07/2023	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Pablo Calamera
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)